Here are five quick things to know:
1. A patient brought the lawsuit against NuVasive and her surgeon, accusing them of intentional misrepresentation and negligence. A pamphlet given to the patient said the system provides “real-time, precise and reliable feedback to ensure your nerve safety” and states the system has been used in more than 60,000 successful spinal surgeries.
2. The ruling said NuVasive knew the device couldn’t “guarantee nerve safety” and was aware of reports the device had a failed.
3. There was a financial relationship between the surgeon and NuVasive.
4. The surgeon and the surgeon’s employer, Regents of the University of California, settled with the patient for $1.75 million before the case went to trial.
5. NuVasive maintains the company did not conspire to misrepresent the product’s efficacy and there weren’t legal claims at trial that the company’s products or equipment “failed to operate as planned.”
More articles on orthopedic devices:
6 new device launches & releases
Medtronic sets its sights on China—5 things to know
Global surgical robot markets poised for rapid growth
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
